Adjuvant sunitinib in high-risk patients with uveal melanoma: A pilot study

被引：0
|
作者：
Valsecchi, Matias Emanuel
Shockley, Nancy
Summers, Deborah
Shields, Carol L.
Shields, Jerry A.
Mastrangelo, Michael J.
Sato, Takami
机构：
[1] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med Oncol, Philadelphia, PA 19107 USA
[2] Genesis Healthcare, Kennett Sq, PA USA
[3] Wills Eye Inst, Oncol Serv, Philadelphia, PA USA
[4] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8560
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma Comparison with Institutional Controls
    Valsecchi, Matias E.
    Orloff, Marlana
    Sato, Rino
    Chervoneva, Inna
    Shields, Carol L.
    Shields, Jerry A.
    Mastrangelo, Michael J.
    Sato, Takami
    OPHTHALMOLOGY, 2018, 125 (02) : 210 - 217
  • [2] A randomized phase II study of adjuvant sunitinib or valproic acid in high-risk patients with uveal melanoma.
    Sato, Takami
    Orloff, Marlana M.
    Valsecchi, Matias Emanuel
    Shimada, Ayako
    Chervoneva, Inna
    Sharpe-Mills, Erin
    Klose, Haley
    Norcini, Jessica
    Belinsky, Jill
    Sato, Shingo
    Hulse, Liam
    Shields, Carol L.
    Shields, Jerry A.
    Mastrangelo, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Adjuvant Ipilimumab in High-Risk Uveal Melanoma
    Fountain, Eric
    Bassett, Roland L.
    Cain, Suzanne
    Posada, Liberty
    Gombos, Dan S.
    Hwu, Patrick
    Bedikian, Agop
    Patel, Sapna P.
    CANCERS, 2019, 11 (02):
  • [4] Quality-of-life measurement in high-risk patients with uveal melanoma receiving adjuvant sunitinib or valproic acid
    Maniraho, Regine Nshimiyimana
    Keith, Scott W.
    Orloff, Marlana M.
    Seedor, Rino S.
    Downie, Leah
    Hulse, Liam
    Sato, Shingo
    Sharpe-Mills, Erin
    Sato, Takami
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [5] Adjuvant polypeptide vaccines for high-risk uveal melanoma
    Gaughan, Elizabeth Mary
    Lucchesi, Nicholas
    Jin, Ruyun
    Slingluff, Craig L.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] A pilot study of sunitinib malate in patients with metastatic uveal melanoma
    Mahipal, Amit
    Tijani, Lukman
    Chan, Kathryn
    Laudadio, MaryAnn
    Mastrangelo, Michael J.
    Sato, Takami
    MELANOMA RESEARCH, 2012, 22 (06) : 440 - 446
  • [7] Randomized phase II study of adjuvant sunitinib or valproic acid in high-risk patients with uveal melanoma: The final analysis of cohort 1.
    Seedor, Rino S.
    Orloff, Marlana M.
    Sharpe-Mills, Erin
    Hulse, Liam
    Shelat, Reshma
    Shimada, Ayako
    Chervoneva, Inna
    Shields, Carol L.
    Shields, Jerry A.
    Mastrangelo, Michael J.
    Sato, Takami
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [8] Potential survival benefit of adjuvant sunitinib in high risk uveal melanoma.
    Valsecchi, Matias Emanuel
    Orloff, Marlana M.
    Chervoneva, Inna
    Shields, Carol L.
    Shields, Jerry A.
    Sharpe-Mills, Erin
    Mastrangelo, Michael J.
    Sato, Takami
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma
    Bol, Kalijn F.
    Van den Bosch, Thomas
    Schreibelt, Gerty
    Mensink, Hanneke W.
    Keunen, Jan E. E.
    Kilic, Emine
    Japing, Wouter J.
    Geul, Kaspar W.
    Westdorp, Harm
    Boudewijns, Steve
    Croockewit, Sandra A. J.
    Van Rossum, Michelle M.
    De Goede, Anna L.
    Naus, Nicole C.
    Van der Graaf, Winette T. A.
    Gerritsen, Winald R.
    De Klein, Annelies
    Punt, Cornelis J. A.
    Figdor, Carl G.
    Cohen, Victoria M.
    Paridaens, Dion
    De Vries, I. Jolanda M.
    OPHTHALMOLOGY, 2016, 123 (10) : 2265 - +
  • [10] Adjuvant intra-arterial hepatic fotemustine for high-risk uveal melanoma patients
    Voelter, Verena
    Schalenbourg, Ann
    Pampallona, Sandro
    Peters, Solange
    Halkic, Nermin
    Denys, Alban
    Goitein, Gudrun
    Zografos, Leonidas
    Leyvraz, Serge
    MELANOMA RESEARCH, 2008, 18 (03) : 220 - 224
12345